Dominique L Braun Selected Research

Dominique L Braun Research Topics

19	Infections 11/2022 - 01/2015
6	HIV Infections (HIV Infection) 06/2022 - 11/2014
3	Syphilis 01/2019 - 01/2017
2	Hepatitis C 11/2022 - 01/2015
2	Hypertension (High Blood Pressure) 01/2022 - 11/2021
2	COVID-19 01/2022 - 08/2021
2	Persistent Infection 01/2022 - 10/2019
1	Viremia 01/2022
1	Insulin Resistance 11/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2021
1	Weight Gain 11/2021
1	Opportunistic Infections (Opportunistic Infection) 01/2020
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 10/2018
1	Chronic Hepatitis C 01/2018
1	Hepatitis B 08/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015
1	Coinfection 01/2015
1	Fibrosis (Cirrhosis) 01/2015
1	Disease Progression 01/2014
1	Acute Retroviral Syndrome 01/2014

5	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 08/2016
4	Broadly Neutralizing AntibodiesIBA 01/2022 - 11/2016
3	Pharmaceutical PreparationsIBA 01/2022 - 10/2018
3	AntibodiesIBA 01/2022 - 08/2016
3	AntigensIBA 08/2021 - 01/2018
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2022 - 01/2015
2	dolutegravirIBA 11/2021 - 10/2019
2	Antiviral Agents (Antivirals)IBA 10/2021 - 01/2018
2	NucleotidesIBA 01/2019 - 11/2014
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017 - 08/2016
1	MacrolidesIBA 06/2022
1	Moxifloxacin (Avelox)FDA Link 06/2022
1	VaccinesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	NucleosidesIBA 01/2022
1	Reverse Transcriptase InhibitorsIBA 01/2022
1	IntegrasesIBA 01/2022
1	Integrase InhibitorsIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Raltegravir Potassium FDA Link 11/2021
1	tenofovir alafenamideIBA 11/2021
1	grazoprevirIBA 01/2019
1	EnzymesIBA 01/2019
1	LipidsIBA 01/2019
1	elbasvirIBA 01/2019
1	InterferonsIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Biological ProductsIBA 06/2017
1	Nevirapine (Viramune)FDA Link 01/2017
1	Viral AntigensIBA 11/2016
1	Silybin (Lagosa)IBA 01/2015
1	Ribavirin (Virazole)FDA LinkGeneric 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2014

6	Therapeutics 01/2022 - 01/2015
4	Art Therapy 01/2022 - 01/2020
1	Highly Active Antiretroviral Therapy (HAART) 10/2019